Literature DB >> 30137112

Relay tricyclic Pd(ii)/Ag(i) catalysis: design of a four-component reaction driven by nitrene-transfer on isocyanide yields inhibitors of EGFR.

Devesh M Sawant1, Shivani Sharma, Ramdas S Pathare, Gaurav Joshi, Sourav Kalra, Sukanya Sukanya, Antim K Maurya, Ramesh K Metre, Vijai K Agnihotri, Shahnawaz Khan, Raj Kumar, R T Pardasani.   

Abstract

Synthesis of pyrazolo[1,5-c]quinazolines from four easily available precursors is presented through a one-pot tricyclic Pd(ii)/Ag(i) relay catalysis. The bimetallic relay cascade forges five new chemical bonds by concatenating six discrete chemical steps. The relay catalysis enables four-component assembly of pyrazolo[1,5-c]quinazolines that selectively inhibit EGFR, exhibit apoptosis through the ROS-induced mitochondrial-mediated pathway, and arrest the cell cycle at the G1 phase.

Entities:  

Year:  2018        PMID: 30137112     DOI: 10.1039/c8cc05845h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  3 in total

1.  Anticancer potential of some imidazole and fused imidazole derivatives: exploring the mechanism via epidermal growth factor receptor (EGFR) inhibition.

Authors:  Sourav Kalra; Gaurav Joshi; Manvendra Kumar; Sahil Arora; Harsimrat Kaur; Sandeep Singh; Anjana Munshi; Raj Kumar
Journal:  RSC Med Chem       Date:  2020-07-08

Review 2.  Recent Advances in Palladium-Catalyzed Isocyanide Insertions.

Authors:  Jurriën W Collet; Thomas R Roose; Bram Weijers; Bert U W Maes; Eelco Ruijter; Romano V A Orru
Journal:  Molecules       Date:  2020-10-23       Impact factor: 4.411

3.  Design and Synthesis of Non-Covalent Imidazo[1,2-a]quinoxaline-Based Inhibitors of EGFR and Their Anti-Cancer Assessment.

Authors:  Manvendra Kumar; Gaurav Joshi; Sahil Arora; Tashvinder Singh; Sajal Biswas; Nisha Sharma; Zahid Rafiq Bhat; Kulbhushan Tikoo; Sandeep Singh; Raj Kumar
Journal:  Molecules       Date:  2021-03-09       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.